Regulatory & Legal

With no approved nonsurgical options for plantar fibromatosis, Keenova's new study and late-stage trial offer a significant glimmer of hope for sufferers.

After a brutal 2024 and a massive strategy shift, all eyes are on Stellantis's 2025 earnings. Will the numbers justify its painful pivot away from EVs?

A new platform debuts, offering access to 30,000+ global assets from a single account, aiming to dismantle barriers for long-term retail investors.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

The USB-C market is set to quadruple, driven by global regulations and advanced tech. But what are the hidden costs and who is winning the race to dominate?

Indian startup DUSQ lands ₹24 crore to challenge global sleep-tech giants with a novel platform that promises to restore sleep, not just score it.

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

With $100M from its new IPO, XFLH Capital joins a resurgent SPAC market. But can its Asia-focused strategy overcome a history of investor risk?

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Dr. Bruce Gnade's election to the NAE highlights a career of innovation and his new mission: building the future semiconductor workforce in North Texas.

Facing a massive exodus of players and tax revenue to offshore sites, Finland is dismantling its state monopoly for a regulated online gambling market.

As devastating wildfires become more common, toxic smoke is seeping indoors. Learn about the hidden health risks and the technology that can keep you safe.

California University of Science and Medicine achieves top national accreditation, a major validation of its mission to fix the region's critical doctor shortage.

The offender monitoring firm reversed a $2M loss, posting a $0.5M Q1 profit after focusing on key US states and shedding international assets.

With triple-digit loan volume growth and a landmark AAA rating, Figure Technology Solutions' latest results suggest tokenized assets are finally breaking through.

A new "smart bomb" cancer drug, PB-223, shows complete tumor eradication with minimal toxicity in preclinical studies, setting the stage for a new battle.

A new SEC-registered transfer agent, OpenAgent, launches to bridge blockchain efficiency with institutional compliance, heralding a new era for digital assets.